Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries Brahim Gaies Original Paper 08 February 2022 Pages: 1415 - 1436
Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries Rudy DouvenLukas KauerXiaoxi Zhao Original Paper Open access 07 February 2022 Pages: 1437 - 1453
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies Caroline SteigenbergerMagdalena Flatscher-ThoeniAndrea M. Leiter Original Paper 15 February 2022 Pages: 1455 - 1482
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics Axel C. MühlbacherAndrew SadlerYvonne Jordan Original Paper Open access 09 February 2022 Pages: 1483 - 1496
Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements Eduardo CostaCarolina Santos Original Paper 22 February 2022 Pages: 1497 - 1518
Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014 Laura HirelloMohammad Habibullah PulokMohammad Hajizadeh Original Paper 19 February 2022 Pages: 1519 - 1533
The effect of informal caregiving on medication: evidence from administrative data Magdalena Stroka-Wetsch Original Paper Open access 27 June 2022 Pages: 1535 - 1545
The attractiveness of jobs in the German care sector: results of a factorial survey Martin KroczekJochen Späth Original Paper Open access 18 March 2022 Pages: 1547 - 1562
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database Zuzana ŠpacírováDavid EpsteinJaime Espín Original Paper 26 February 2022 Pages: 1563 - 1575
A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots Elahe KhorasaniMajid DavariVida Varahrami Original Paper 02 March 2022 Pages: 1577 - 1590
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design Simona GambaNiklas JakobssonMikael Svensson Original Paper Open access 25 February 2022 Pages: 1591 - 1599
Looking into the black box of “Medical Innovation”: rising health expenditures by illness type Friedrich BreyerNormann LorenzThomas Schober Original Paper Open access 17 March 2022 Pages: 1601 - 1612
Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology Stefan A. LipmanLiying ZhangArthur E. Attema Correction Open access 05 October 2022 Pages: 1613 - 1615
